Comparison of Vascular Risk in Patients Treated for Obstructive Sleep Apnea/Hypopnea Syndrome
NCT ID: NCT05491967
Last Updated: 2025-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
172 participants
OBSERVATIONAL
2021-03-16
2023-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accelerated Aging in Middle-Aged Men With Sleep-disordered Breathing.
NCT02876653
Unrecognised Obstructive Sleep Apnea Study
NCT01494181
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010
Treatment of Sleep Apnea Syndrome With nCPAP Versus Oral Appliance
NCT00152672
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
NCT05939934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
CPAP is the most effective treatment to reduce the apnea-hypopnea index (AHI). However, its tolerance is sometimes difficult, causing many discontinuations.
The purpose of this review is to evaluate a vascular morbimortality criteria:
* Cardiovascular: myocardial infarction, heart failure, rhythm disorder
* Neurological: transient or non transient stroke
* ophthalmologic: anterior ischemic optic neuropathy, occlusion of the central artery or central retinal vein occlusion
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous Positive Airway Pressure (CPAP)
Obstructive Sleep Apnea/Hypopnea Syndrome treated with Continuous Positive Airway Pressure (CPAP
No interventions assigned to this group
Mandibular Advancement Orthosis
Obstructive Sleep Apnea/Hypopnea Syndrome treated with Mandibular Advancement Orthosis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years old
* Read, write and understand the French language
Exclusion Criteria
* Refusal to participate in research
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Valence
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ch Valence
Valence, Drome, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIPH-CHV-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.